Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

About FDA

Webinar on FDA’s Safety Monitoring of Approved Vaccines

DATE:  July 13, 2010

TIME:  2:00 PM

LENGTH:  30 minutes

Did you know that FDA’s review of vaccine safety doesn’t stop once a vaccine is approved?  Why is it important to have different types of systems to perform safety surveillance for approved vaccines?

On Tuesday, July 13th, FDA hosted a webinar about the agency’s work to ensure the safety of vaccines.  Andrea Sutherland, MD, MPH, Msc, who is a medical officer and Special Assistant to the Director of the Division of Epidemiology in the Office of Biostatistics and Epidemiology in FDA’s Center for Biologics Evaluation and Research, provided an overview and answered questions about vaccine safety surveillance, including the Vaccine Adverse Event Reporting System (or VAERS), and efforts underway to improve safety monitoring.  Currently, FDA is working with federal, international, academic, and health care partners to further improve its ability to evaluate the safety of vaccines throughout the lifecycle of products.

Watch the archived version of the Webinar: CBER VAERS Vaccine Safety

Download Presentation Slides (PDF - 103 KB)

Page Last Updated: 07/13/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English